Literature DB >> 21791594

In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits.

Damian E Berezovsky1, Samirkumar R Patel, Bernard E McCarey, Henry F Edelhauser.   

Abstract

PURPOSE: To evaluate the transscleral delivery of fluoresceinated dextrans (FITC-D) with molecular mass up to 70 kDa to the rabbit posterior segment using sub-Tenon injections.
METHODS: Eighteen NZW rabbits received a unilateral 200-μL injection of 2 mg/mL sodium fluorescein (NaF), 25 mg/mL 40-kDa FITC-D, or 25 mg/mL 70-kDa FITC-D, with (n = 9) or without (n = 9) immediate euthanatization. In live animals, fluorescence was measured in the retina/choroid and mid-vitreous by fluorophotometry, immediately after injection and after 4, 24, 48, and 72 hours. Euthanatized animals were examined hourly through 5 or 6 hours.
RESULTS: In live animals, the average peak NaF concentration in the retina/choroid was 310.2 ng/mL, measured 3 hours after injection. Average 40- and 70-kDa FITC-D concentrations in the retina/choroid peaked at 5409.6 and 2375.6 ng/mL, respectively, 24 hours after injection. Fluorescence returned to baseline levels 6 hours after NaF injection, and 48 and 72 hours after 40- and 70-kDa FITC-D injections, respectively. Rabbits that received NaF followed by euthanatization exhibited a continuous increase in retina/choroid and mid-vitreous fluorescence, beginning 1 hour after injection, whereas FITC-D-injected eyes did not show elevated retina/choroid or mid-vitreous fluorescence through 6 hours.
CONCLUSIONS: FITC-D weighing up to 70-kDa, as well as NaF, reached the posterior retina/choroid after sub-Tenon injections in live rabbits. NaF and 40-kDa FITC-D reached higher peak concentrations and were cleared from the eye more rapidly than was 70-kDa FITC-D. There was minimal penetration of NaF and FITC-D into the mid-vitreous in the in vivo experiments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791594      PMCID: PMC3207710          DOI: 10.1167/iovs.11-7207

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  30 in total

Review 1.  Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

Authors:  M R Prausnitz; J S Noonan
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

2.  Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application.

Authors:  Lijun Shen; Yongsheng You; Shumao Sun; Yiqi Chen; Jia Qu; Lingyun Cheng
Journal:  Ophthalmology       Date:  2010-08-03       Impact factor: 12.079

3.  The collagen architecture of the sclera--SEM and immunohistochemical studies.

Authors:  A Thale; B Tillmann
Journal:  Ann Anat       Date:  1993-06       Impact factor: 2.698

4.  Studies on the technique of vitreous fluorophotometry.

Authors:  R C Zeimer; J G Cunha-Vaz; M E Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-05       Impact factor: 4.799

5.  Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity.

Authors:  Leena Pitkänen; Veli-Pekka Ranta; Hanna Moilanen; Arto Urtti
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-02       Impact factor: 4.799

6.  Diffusion of high molecular weight compounds through sclera.

Authors:  J Ambati; C S Canakis; J W Miller; E S Gragoudas; A Edwards; D J Weissgold; I Kim; F C Delori; A P Adamis
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-04       Impact factor: 4.799

7.  Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.

Authors:  T W Olsen; H F Edelhauser; J I Lim; D H Geroski
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-08       Impact factor: 4.799

8.  Outward transport of fluorescein from the vitreous in normal human subjects.

Authors:  N P Blair; R C Zeimer; M M Rusin; J G Cunha-Vaz
Journal:  Arch Ophthalmol       Date:  1983-07

9.  Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.

Authors:  Hyuncheol Kim; Michael R Robinson; Martin J Lizak; Ginger Tansey; Robert J Lutz; Peng Yuan; Nam S Wang; Karl G Csaky
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

Review 10.  Vitreous fluorophotometry: a review.

Authors:  M F Raines
Journal:  J R Soc Med       Date:  1988-07       Impact factor: 18.000

View more
  6 in total

1.  Ocular Drug Distribution and Safety of a Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in Rabbit.

Authors:  Kongnara Papangkorn; John W Higuchi; Balbir Brar; William I Higuchi
Journal:  J Ocul Pharmacol Ther       Date:  2018-02-12       Impact factor: 2.671

2.  Ocular delivery of pRNA nanoparticles: distribution and clearance after subconjunctival injection.

Authors:  Liang Feng; S Kevin Li; Hongshan Liu; Chia-Yang Liu; Kathleen LaSance; Farzin Haque; Dan Shu; Peixuan Guo
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

3.  Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in the Treatment of Experimental Uveitis Rabbit.

Authors:  Kongnara Papangkorn; Eri Prendergast; John W Higuchi; Balbir Brar; William I Higuchi
Journal:  J Ocul Pharmacol Ther       Date:  2017-10-12       Impact factor: 2.671

4.  Fluorophotometric Determination of Riboflavin Concentrations in a Human Artificial Anterior Chamber Model.

Authors:  Katja C Iselin; Michael A Thiel; Lucas M Bachmann; Philipp B Baenninger; Claude Kaufmann
Journal:  Transl Vis Sci Technol       Date:  2019-11-12       Impact factor: 3.283

5.  Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry.

Authors:  Puneet Tyagi; Rajendra S Kadam; Uday B Kompella
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

6.  Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes.

Authors:  Rajendra S Kadam; Jason Williams; Puneet Tyagi; Henry F Edelhauser; Uday B Kompella
Journal:  Mol Vis       Date:  2013-05-30       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.